Table 3

 Tau-B and SE of agreement between clinical assessment (Y91), blood alcohol concentration (BAC) (Y90), and interviewer assessment (IA) by country

nY91 v Y90IA v Y91*IA v Y90*
Total6 hours drinkersFemaleMalePositive RAPS4Negative RAPS4TotalTotal
*Interviewer assessment was only conducted in Belarus, Brazil, China, and India.
†New Zealand study did not ask RASP4 and tolerance question.
‡Not available because distribution of Y90/Y91 has no variability.
§Excluded from homogeneity test and pooled effect size to have comparable estimates.
¶Only 105 respondents were assessed by interviewer in India study.
Argentina4240.65 (0.05)0.42 (0.07)0.49 (0.18)0.66 (0.05)0.53 (0.09)0.62 (0.06)
Belarus4570.70 (0.03)0.47 (0.06)0.69 (0.08)0.67 (0.04)0.67 (0.05)0.67 (0.06)0.81 (0.03)0.74 (0.03)
Brazil4780.63 (0.06)0.35 (0.12)0.66 (0.18)0.61 (0.07)0.53 (0.10)0.67 (0.10)0.86 (0.03)0.60 (0.06)
Canada2060.50 (0.31)0.48(0.34)NA‡§0.71 (0.25)§0.71 (0.25)§N/A‡§
China4530.70 (0.07)0.33(0.17)0.57 (0.24)0.71 (0.08)0.66 (0.17)0.52 (0.13)0.99 (0.003)0.71 (0.08)
Czech Republic4550.35 (0.13)0.27(0.18)NA‡§0.38 (0.14) §0.35 (0.20)0.32 (0.18)
India5440.54 (0.04)0.16 (0.08)0.81 (0.17)0.51 (0.04)0.21 (0.09)0.62 (0.06)0.71 (0.08)¶0.31 (0.11)¶
Mexico3860.59 (0.06)0.29 (0.10)0.65 (0.12)0.58 (0.07)0.50 (0.10)0.65 (0.08)
Mozambique4450.72 (0.05)0.30 (0.10)0.58 (0.22)0.71 (0.05)0.71 (0.09)0.69 (0.06)
New Zealand†1190.68 (0.07)0.34 (0.13)0.83 (0.11)0.65 (0.08)
South Africa4540.72 (0.02)0.44 (0.05)0.79 (0.05)0.70 (0.03)0.55 (0.05)0.69 (0.04)
Sweden3770.76 (0.05)0.61 (0.06)0.62 (0.14)0.80 (0.05)0.75 (0.05)0.77 (0.10)
Test of homogeneityQ = 27.3 (df = 11) p = 0.004Q = 25.4 (df = 11) p = 0.008Q = 6.8 (df = 9) p = 0.654Q = 23.9 (df = 9) p = 0.004Q = 35.7 (df = 9) p = 0.000Q = 7.8 (df = 9) p = 0.551
Fixed effect0.68 (0.01)0.41 (0.03)0.74 (0.03)0.67 (0.02)0.60 (0.02)0.66 (0.02)
Random effect0.66 (0.03)0.38 (0.04)0.74 (0.03)0.66 (0.03)0.56 (0.05)0.66 (0.02)